JPMorgan Chase & Co’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-124,573
| Closed | -$15.1M | – | 6423 |
|
|
2023
Q1 | $15.1M | Sell |
124,573
-69,899
| -36% | -$8.46M | ﹤0.01% | 1681 |
|
|
2022
Q4 | $22.3M | Buy |
194,472
+44,370
| +30% | +$5.09M | ﹤0.01% | 1366 |
|
|
2022
Q3 | $15.2M | Buy |
150,102
+13,319
| +10% | +$1.35M | ﹤0.01% | 1572 |
|
|
2022
Q2 | $13.9M | Buy |
136,783
+133,354
| +3,889% | +$13.5M | ﹤0.01% | 1678 |
|
|
2022
Q1 | $399K | Sell |
3,429
-23,596
| -87% | -$2.75M | ﹤0.01% | 4125 |
|
|
2021
Q4 | $3.1M | Buy |
+27,025
| New | +$3.1M | ﹤0.01% | 2912 |
|
|
2020
Q4 | – | Sell |
-7,626
| Closed | -$853K | – | 5188 |
|
|
2020
Q3 | $853K | Buy |
7,626
+3,998
| +110% | +$447K | ﹤0.01% | 3164 |
|
|
2020
Q2 | $380K | Buy |
+3,628
| New | +$380K | ﹤0.01% | 3399 |
|